Diebold (DBD) Tops Q2 EPS by 22c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $63.20 -0.46%
Financial Fact:
Income from continuing operations, net of tax: -21.6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Income from continuing operations, net of tax: -21.6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Diebold (NYSE: DBD) reported Q2 EPS of $0.43, $0.22 better than the analyst estimate of $0.21. Revenue for the quarter came in at $580 million versus the consensus estimate of $594.01 million.
Adjusted EBITDA was $53.9 million, or 9.3% of revenue, in the second quarter 2016, compared with $57.5 million, or 8.9% of revenue, in the second quarter 2015.
Diebold reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Diebold (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Anthropic delays planned IPO from October to November - WSJ
- Amneal gets FDA approval for lanreotide injection, launches immediately
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
